The mission of the European Academic Drug Discovery SIG is to recognise and respond to the unique nature of the networks and interactions across Europe and in so doing enable greater interaction between academia, pharmaceutical research companies, suppliers and other technical companies.
Effective management of compound collections is crucial to the success of the early discovery efforts of the Pharmaceutical, Biotechnology and Agri-Science industries. In addition, academic organisations are also establishing comprehensive compound management infrastructures to help realise their target validation and drug discovery goals.
The SLAS Europe SIG on Compound Management in Industry and Academia is designed to facilitate exchanges of ideas, best practices, issues and solutions between key individuals who share the aims of providing their organizations with the right compound at the right time and in the best possible quality, to allow the generation of meaningful screening, pharmacological, toxicological or ADME profiling data.
The SLAS Europe LinkedIn group enables interaction between life science research and development professionals including scientists, technology providers, researchers, academics and students, engineers, informatics specialists, and business leaders located in Europe.